BACKGROUND:Arginine is considered an essential amino acid during critical illness in children, and supplementation of arginine has been proposed to improve arginine availability to facilitate nitric oxide (NO) synthesis. Protein-energy-enriched enteral formulas (PE-formulas) can improve nutrient intake and promote anabolism in critically ill infants. However, the effect of increased protein and energy intake on arginine metabolism is not known. OBJECTIVE: We investigated the effect of a PE-formula compared with that of a standard infant formula (S-formula) on arginine kinetics in critically ill infants. DESIGN: A 2-h stable-isotope tracer protocol was conducted in 2 groups of critically ill infants with respiratory failure because of viral bronchiolitis, who received either a PE-formula (n = 8) or S-formula (n = 10) in a randomized, blinded, controlled setting. Data were reported as means ± SDs. RESULTS: The intake of a PE-formula in critically ill infants (aged 0.23 ± 0.14 y) resulted in an increased arginine appearance (PE-formula: 248 ± 114 μmol · kg(-1) · h(-1); S-formula: 130 ± 53 μmol · kg(-1) · h(-1); P = 0.012) and NO synthesis (PE-formula: 1.92 ± 0.99 μmol · kg(-1) · h(-1); S-formula: 0.84 ± 0.36 μmol · kg(-1) · h(-1); P = 0.003), whereas citrulline production and plasma arginine concentrations were unaffected. CONCLUSION: In critically ill infants with respiratory failure because of viral bronchiolitis, the intake of a PE-formula increases arginine availability by increasing arginine appearance, which leads to increased NO synthesis, independent of plasma arginine concentrations. This trial was registered at www.trialregister.nl as NTR515.
RCT Entities:
BACKGROUND:Arginine is considered an essential amino acid during critical illness in children, and supplementation of arginine has been proposed to improve arginine availability to facilitate nitric oxide (NO) synthesis. Protein-energy-enriched enteral formulas (PE-formulas) can improve nutrient intake and promote anabolism in critically ill infants. However, the effect of increased protein and energy intake on arginine metabolism is not known. OBJECTIVE: We investigated the effect of a PE-formula compared with that of a standard infant formula (S-formula) on arginine kinetics in critically ill infants. DESIGN: A 2-h stable-isotope tracer protocol was conducted in 2 groups of critically ill infants with respiratory failure because of viral bronchiolitis, who received either a PE-formula (n = 8) or S-formula (n = 10) in a randomized, blinded, controlled setting. Data were reported as means ± SDs. RESULTS: The intake of a PE-formula in critically ill infants (aged 0.23 ± 0.14 y) resulted in an increased arginine appearance (PE-formula: 248 ± 114 μmol · kg(-1) · h(-1); S-formula: 130 ± 53 μmol · kg(-1) · h(-1); P = 0.012) and NO synthesis (PE-formula: 1.92 ± 0.99 μmol · kg(-1) · h(-1); S-formula: 0.84 ± 0.36 μmol · kg(-1) · h(-1); P = 0.003), whereas citrulline production and plasma arginine concentrations were unaffected. CONCLUSION: In critically ill infants with respiratory failure because of viral bronchiolitis, the intake of a PE-formula increases arginine availability by increasing arginine appearance, which leads to increased NO synthesis, independent of plasma arginine concentrations. This trial was registered at www.trialregister.nl as NTR515.
Authors: Marlieke Visser; Mechteld A R Vermeulen; Milan C Richir; Tom Teerlink; Alexander P J Houdijk; Piet J Kostense; Willem Wisselink; Bas A J M de Mol; Paul A M van Leeuwen; Heleen M Oudemans-van Straaten Journal: Br J Nutr Date: 2011-12-01 Impact factor: 3.718
Authors: L Castillo; T E Chapman; M Sanchez; Y M Yu; J F Burke; A M Ajami; J Vogt; V R Young Journal: Proc Natl Acad Sci U S A Date: 1993-08-15 Impact factor: 11.205
Authors: Carlijn T I de Betue; Xiomara C Garcia Casal; Dick A van Waardenburg; Stephen M Schexnayder; Koen F M Joosten; Nicolaas E P Deutz; Marielle P K J Engelen Journal: Clin Nutr Date: 2017-01-04 Impact factor: 7.324
Authors: Juan C Marini; Umang Agarwal; Jason L Robinson; Yang Yuan; Inka C Didelija; Barbara Stoll; Douglas G Burrin Journal: Am J Physiol Endocrinol Metab Date: 2017-06-13 Impact factor: 4.310
Authors: Robert H Coker; Kenneth Shin; Kristen Scholten; Michelle Johannsen; Jean Tsigonis; Il-Young Kim; Scott E Schutzler; Robert R Wolfe Journal: Clin Nutr Date: 2018-12-19 Impact factor: 7.324
Authors: Lyvonne N Tume; Frederic V Valla; Koen Joosten; Corinne Jotterand Chaparro; Lynne Latten; Luise V Marino; Isobel Macleod; Clémence Moullet; Nazima Pathan; Shancy Rooze; Joost van Rosmalen; Sascha C A T Verbruggen Journal: Intensive Care Med Date: 2020-02-20 Impact factor: 17.440
Authors: Il-Young Kim; Scott E Schutzler; Amy Schrader; Horace J Spencer; Gohar Azhar; Nicolaas E P Deutz; Robert R Wolfe Journal: Am J Physiol Endocrinol Metab Date: 2015-10-06 Impact factor: 4.310
Authors: David D Church; Katie R Hirsch; Sanghee Park; Il-Young Kim; Jess A Gwin; Stefan M Pasiakos; Robert R Wolfe; Arny A Ferrando Journal: Nutrients Date: 2020-12-02 Impact factor: 5.717